At the institute's 42nd convocation ceremony, Union Minister described its eight-institution MoU initiative as a unique collaborative effort that brings together premier national institutions to create a synergistic research ecosystem
Lormalzi is the first and only once-monthly amyloid plaque-targeting therapy with clinical evidence
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
Surgeon Yuvaraja operates on a 55-year-old patient at Medical City Hospital Muscat
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
The once-weekly treatment targets Type 2 Diabetes Mellitus (T2DM) with demonstrated efficacy and safety
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The cancellation underscores the regulator’s strict stance against misleading cosmetic claims
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
